Connect with us

Technology

YouScript Wins “PharmaTech Innovation Award” in 9th Annual MedTech Breakthrough Awards Program

Published

on

Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies

SEATTLE, May 8, 2025 /PRNewswire/ — YouScript®, an Aranscia company, today announced that it is the recipient of the “PharmaTech Innovation Award” award in the 9th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global digital health and medical technology market.

The 2025 MedTech Breakthrough Award recognizes the industry-leading innovations of the YouScript Precision Prescribing platform and its positive impact on millions of patients’ lives. As one of the foundational leaders in personalized medication management for over two decades, YouScript’s award-winning solutions, extensive program experience, and tested and proven operations teams provide distinct advantages in the design, execution, and success of personalized prescribing programs. Studies show that that YouScript-powered programs have helped to reduce hospitalizations and emergency department visits by 39% and 71%, respectively.

The power of YouScript’s technology platform lies within intuitive capabilities that assist providers to make intelligent, proactive medication decisions at the point of care. YouScript provides evidence-based guidance on drug and dose selection incorporating pharmacogenomics (PGx), drug-drug interactions, and phenoconversion, plus a patented framework for proactive risk assessments to highlight the direct potential impact of personalized prescribing. YouScript’s decision support technologies, which contain drug-gene insights from over 19,000 high-evidence references covering over 2,000 medications, are widely available via EMR integrations, standalone applications, and APIs.

“YouScript’s suite of technology and program solutions highlight a foundational mission to help unlock the true power of precision prescribing for all,” said Kristine Ashcraft, Founder and President of YouScript. “We are proud of our continued growth and expansion as a trusted partner to value-based healthcare organizations, providers, and payers, and we thank MedTech Breakthrough for this incredible recognition.”

The MedTech Breakthrough Awards program celebrates excellence and innovation in the health and medical technology industry, recognizing the companies, products, and solutions driving meaningful progress and improving patient care. Spanning a wide range of categories—including Telehealth, Clinical Administration, Patient Engagement, Electronic Health Records (EHR), Virtual Care, Medical Devices, Medical Data & Privacy, and beyond—the awards highlight the groundbreaking work that is transforming the healthcare landscape.

This year’s program saw a record-breaking number of nominations from leading companies and startups across more than 18 countries, showcasing the global impact and momentum of the digital healthcare industry today.

“YouScript is an industry-leading provider of medication management solutions that unlock the true power of precision prescribing for all,” said Steve Johansson, managing director, MedTech Breakthrough. “YouScript identifies substantially more major issues than typical drug-drug interaction programs, allowing healthcare providers to reduce trial-and-error prescribing, reduce costs, and improve patient outcomes. We’re thrilled to award YouScript with the ‘PharmaTech Innovation Award!'”

YouScript technology is also now powering alerting-based precision medicine solutions for thousands of individual client groups, pharmacy systems, long-term care systems, and pharmacy benefit managers that collectively support millions of patient lives.

About YouScript
YouScript is a leader in pharmacogenomics research, insights, and software solutions that help make precision prescribing possible. YouScript’s lab-agnostic PGx risk, insights, and reference solutions assist clinical professionals to make fast, proactive decisions at the point of care. YouScript’s PGx program support and research initiatives span more than two decades and have often served as a foundational basis for best practices in assessing categorial risk and measuring outcomes across the entire PGx industry. For more information, please visit www.youscript.com.

About Aranscia
Aranscia delivers world-class diagnostic software, services, and testing innovations that help clinicians improve care outcomes. The Aranscia portfolio of companies, which includes 2bPrecise, AccessDx Laboratory, and YouScript, have extensive practical expertise in molecular diagnostics, genomics, and digital-first clinical workflows. Aranscia enables clinical organizations to effectively utilize precision diagnostics for turnkey programs in fields such as pharmacogenomics, infectious disease management, precision oncology, and genetic screening. With a dual focus on simplicity and scalability, Aranscia’s portfolio companies are the ideal partner for long-term, value-based precision medicine initiatives. For more information, please visit www.aranscia.com

About MedTech Breakthrough
Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is devoted to honoring excellence and innovation in medical & health technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough healthcare and medical companies and products in categories that include Patient Experience & Engagement, Health & Fitness, Medical Devices, Clinical Administration, Connected Healthcare, Medical Data, Healthcare Cybersecurity and more. For more information visit MedTechBreakthrough.com

Tech Breakthrough LLC does not endorse any vendor, product or service depicted in our recognition programs, and does not advise technology users to select only those vendors with award designations. Tech Breakthrough LLC recognition consists of the opinions of the Tech Breakthrough LLC organization and should not be construed as statements of fact. Tech Breakthrough LLC disclaims all warranties, expressed or implied, with respect to this recognition program, including any warranties of merchantability or fitness for a particular purpose.

Media Contact:
Karina Stabile
394951@email4pr.com
(516) 317-5835

View original content to download multimedia:https://www.prnewswire.com/news-releases/youscript-wins-pharmatech-innovation-award-in-9th-annual-medtech-breakthrough-awards-program-302450330.html

SOURCE YouScript

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Jtibot Showcases Autonomous Outdoor Sweeping Innovation at Interclean Amsterdam 2026, Accelerating European Market Expansion

Published

on

By

AMSTERDAM, April 24, 2026 /PRNewswire/ — Jtibot, a developer of autonomous outdoor cleaning solutions, concluded a successful showcase at Interclean Amsterdam 2026, highlighting its focus on large-scale, AI-driven sweeping for industrial, municipal, and campus environments.

At Hall 8, Booth 538, Jtibot presented its autonomous outdoor sweeper designed for environments exceeding 10,000 sqm. Positioned between traditional equipment and emerging robotics, the system addresses the growing demand for more efficient and less labor-dependent outdoor cleaning operations.

During the exhibition, Jtibot attracted strong interest from European distributors and facility management professionals seeking scalable solutions for large-area maintenance. The company was also featured in an official media interview at the event, reflecting increasing attention toward autonomous technologies in the cleaning industry.

Jtibot’s approach centers on human-machine collaboration. By reducing repetitive manual work while maintaining operational flexibility, its systems support more sustainable and efficient facility management practices. This aligns with broader ESG (Environmental, Social, and Governance) priorities, including improved resource efficiency and enhanced working conditions.

Building on its presence at Interclean, Jtibot is currently advancing discussions with multiple European partners for regional distribution and deployment. The company is also in the final stage of a fleet procurement agreement valued at approximately $1.4 million, signaling early commercial traction in large-scale applications scenarios.

“As outdoor environments continue to grow in scale and complexity, automation is becoming essential,” said Steven, VP at Jtibot. “Our goal is not to replace people, but to empower them—making operations more efficient and labor more sustainable.”

Following Interclean Amsterdam 2026, Jtibot is actively expanding its European partner network and preparing for broader market deployment across key regions, as it accelerates its global commercialization strategy.

About Jtibot
Jtibot specializes in autonomous outdoor sweepers designed for large-scale environments. By combining AI-driven navigation with industrial-grade hardware, the company enables efficient, scalable, and sustainable cleaning operations worldwide.

Photo – https://mma.prnewswire.com/media/2965027/PR_image.jpg

View original content:https://www.prnewswire.co.uk/news-releases/jtibot-showcases-autonomous-outdoor-sweeping-innovation-at-interclean-amsterdam-2026-accelerating-european-market-expansion-302752777.html

Continue Reading

Technology

2U Refinances and Raises Growth Capital

Published

on

By

ARLINGTON, Va., April 24, 2026 /PRNewswire/ — Many education technology companies spent 2024 and 2025 scaling back. New university partnerships slowed as institutions built internal capacity. Against that backdrop, 2U completed a growth recapitalization, with its existing owners putting growth capital into the business alongside a refinancing of its current credit facilities.

The question worth asking is: why now, and what did they see?

2U operates edX, a global online learning platform originally co-founded by Harvard and MIT that now reaches more than 100 million people through over 5,300 programs with 250-plus institutional and enterprise partners. Employees from more than 60% of Fortune 500 companies use edX for professional development. To date, over 76,000 people have graduated from 2U-powered degree programs from leading institutions, including UC Berkeley, Howard University, and Georgetown. The company has been privately held since completing a financial reorganization in 2024, and Kees Bol has served as CEO since January 2025.

Lincoln International, which advised 2U on the transaction exclusively, described the refinancing outcome: extended credit maturities, improved capital structure, and financial flexibility to continue executing on 2U’s long-range plan. Managing Director Alex Stevenson said the deal “reflects the confidence of 2U’s owners in the long-term value of the business.”

Confidence in what, exactly? The AI workforce training market. Skills in AI-affected roles are evolving 66% faster than average according to PwC research, and IDC has estimated that unfilled AI skills gaps could cost the global economy $5.5 trillion. Universities and enterprises are both trying to solve that problem, and both are looking for platforms with the breadth and accreditation backing to do it credibly.

2U’s partnerships are designed for exactly that. IBM’s six technical microcredentials on edX train the engineers and data scientists who build AI systems. Microsoft’s CxO Edge program, launched in late 2025, targets the C-suite executives who need to move from AI pilots to enterprise-wide adoption, part of a Microsoft presence on edX that has drawn over 40,000 learners in the past six months alone.. Oxford’s Faculty of Law program addresses governance: what board members and legal advisors need to understand about AI liability, compliance, and fiduciary responsibility. UC Berkeley’s Master of Information and Data Science (MIDS) online program prepares learners to shape the future of AI and data science with human-centered values and focuses on solving the world’s most pressing data challenges. Each program exists because a specific employer community identified a specific gap.

That’s the differentiation investors are backing. Generic online courses are abundant. Programs designed in partnership with IBM, Microsoft, UC Berkeley, and Oxford’s Faculty of Law and delivered on a platform with proven Fortune 500 adoption are not.

Credentials earned on 2U’s edX platform carry the academic standing of the issuing partner institutions. Its programs span executive education, professional certificates, microcredentials, and accredited online degree programs, all powered by 2U’s infrastructure but conferred by partner universities and institutions with their own accreditation.

HolonIQ data puts the broader trend in context: microcredentials grew from 7% of global online program offerings in 2022 to 19% by 2025. The shift toward stackable, job-aligned credentials, in addition to traditional degrees,  is real and accelerating. The global online education market is projected to exceed $200 billion as that trend matures. 2U’s decision to build depth in short-form, employer-designed AI training aligns directly with where learner demand is heading.

None of this is abstract for the organizations that use edX at scale. When a company needs to certify 500 engineers on AI development, or prepare its entire C-suite for a board presentation on AI governance, the platform’s reach and credential quality both matter. A certification backed by IBM and a degree from institutions such as Berkeley carries weight with hiring managers in a way a generic online course does not.

The refinancing extends 2U’s ability to keep building that catalog and the partnerships behind it. Stevenson framed it as giving the management team “the financial foundation to keep executing on its mission.” The mission, under Bol’s leadership, is straightforward: help universities and enterprises close the AI skills gap by meeting learners where they are, at the pace the market demands.

The investors who contributed growth capital made a bet that a platform that reaches 100 million people and has 250-plus partners, including IBM, Microsoft, UC Berkeley, and Oxford in its program portfolio, is better positioned to close that gap than any platform that would need to build from scratch.

Media Contact:
Kees Bol
social@2u.com 

Logo: https://mma.prnewswire.com/media/2965091/2U_Logo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/2u-refinances-and-raises-growth-capital-302752776.html

Continue Reading

Technology

Autonomous Resource Corporation and Oak Ridge National Laboratory Partner to Accelerate AI-Enabled Defense Manufacturing at National Scale

Published

on

By

Strategic partnership combines ORNL’s supercomputing and advanced manufacturing expertise with ARC’s autonomous production platform to address critical defense industrial base shortfalls

OAK RIDGE, Tenn. and NEW YORK, April 24, 2026 /PRNewswire/ — Autonomous Resource Corporation (ARC), a Delaware corporation, and Oak Ridge National Laboratory (ORNL), the U.S. Department of Energy’s largest multi-program science and energy laboratory, today announced a Memorandum of Understanding (MOU) establishing a strategic public-private partnership to accelerate the on-demand manufacture of qualified, mission-critical components for U.S. national security applications.

The partnership combines ORNL’s HPC and manufacturing capability with ARC’s ARCNet distributed AI-manufacturing platform

The partnership — known as the Exascale Foundry — will combine ORNL’s computing and manufacturing capabilities with ARC’s ARCNet distributed manufacturing platform to create a closed-loop system for AI-enabled materials and manufacturing qualification and autonomous production at defense-relevant scale.

“The United States faces an urgent need to rebuild its manufacturing capacity for critical defense components,” said Bryan Wisk, CEO of ARC. “By combining ORNL’s world-leading computational, materials science, and manufacturing capabilities with our autonomous production infrastructure, we can compress manufacturing and qualification timelines from years to months and deliver manufactured parts at the volumes the warfighter needs.”

Partnership Highlights

Under the MOU, ARC will deploy advanced manufacturing equipment organized into seven production nodes connected to ORNL via ARC’s secure ARCNet infrastructure. ARC will expand capability through ORNL’s high-performance computing (HPC) resources.

ORNL will provide access to HPC expertise for simulation-driven materials characterization and qualification, along with technologies developed at the Manufacturing Demonstration Facility (MDF), the Department of Energy’s only large-scale, open-access advanced manufacturing facility. ORNL’s Peregrine AI software, which has analyzed over 1.9 million additive manufacturing layers, will be integrated into ARC’s production nodes for real-time adaptive control and quality assurance.

This partnership also supports DOE’s Genesis Mission, a national initiative to build the world’s most powerful scientific platform to accelerate discovery science, strengthen national security and drive energy innovation. ARC and ORNL’s collective capabilities will help reenvision advanced manufacturing and industrial productivity, accelerate defense production and qualification, and secure critical supply chain elements.

“ORNL’s advanced manufacturing and computing capabilities are uniquely positioned to help accelerate the transition of laboratory-proven technologies into production-scale defense manufacturing,” said Moe Khaleel, ORNL associate laboratory director for National Security Sciences. “Partnering with ARC ensures we are transitioning our research into real production outcomes.”

The initial implementation will focus on high-temperature nickel superalloy turbine components for autonomous air vehicle engines using metal binder jetting technology, directly addressing demonstrated production bottlenecks in the U.S. defense supply chain.

ORNL Chief Manufacturing Officer Craig Blue added, “This partnership exemplifies the type of relationship necessary to build and grow domestic supply chains for our national security.”

About Autonomous Resource Corporation

ARC is a New York–headquartered corporation building and operating an AI-enabled, autonomous manufacturing platform for national security and critical infrastructure applications. ARC’s Autonomous Resource Controller Network (ARCNet) connects distributed production cells into a secure, federated manufacturing grid capable of producing qualified components at scale. ARC’s leadership team brings deep experience across defense technology, capital markets, materials science, and additive manufacturing at production scale.

About Oak Ridge National Laboratory

Oak Ridge National Laboratory is the largest U.S. Department of Energy science and energy laboratory, conducting basic and applied research to deliver transformative solutions to compelling problems in energy and security. DOE’s Manufacturing Demonstration Facility at ORNL partners with more than 300 companies, spurring over $5.5 billion in economic growth. ORNL is managed by UT-Battelle, LLC for the U.S. Department of Energy’s Office of Science.

Media Contacts:

ARC: Bryan Wisk, Chief Executive Officer | bryan@autonomousresource.com | 929-523-3953

ORNL: Eric Swanson, National Security Sciences Communications Lead | swansonej@ornl.gov | 865-206-5794

View original content to download multimedia:https://www.prnewswire.com/news-releases/autonomous-resource-corporation-and-oak-ridge-national-laboratory-partner-to-accelerate-ai-enabled-defense-manufacturing-at-national-scale-302752414.html

SOURCE Autonomous Resource Corporation

Continue Reading

Trending